封面
市场调查报告书
商品编码
1424470

多重检测的全球市场:按产品类型、按技术、按应用、按最终用户、按地区

Global Multiplex Assay Market, By Product, By Type, By Technology, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3个工作天内

价格
简介目录

多重检测的全球市场规模预计将从 2024 年的 16.9 亿美元增至 2031 年的 44 亿美元,预测期内复合年增长率为 14.6%。

报告范围 报告详情
基准年 2023年 2023/2024年市场规模 16.9亿美元
实际资料 2019年至2023年 预测期 2024-2031
预测期2023/2024~2030/2031年复合成长率: 14.60% 2030/2031价值预测 44亿美元
图 1. 2024 年按地区分類的多重检测的全球市场占有率(%)
全球多重检测市场-IMG1

近年来,由于慢性病和感染疾病的全球盛行率不断上升,多重检测市场经历了显着增长。多重分析允许在一次测定中同时检测多种分析物,从而提高诊断准确性和通量。这使得实验室能够简化其测试流程,同时最大限度地降低营运成本。各种技术进步,包括微阵列和以微珠为基础的技术,正在促进用于临床诊断和研究应用的灵敏、高度特异性和高通量多重平台的开发。展望未来,越来越多的老年人口更容易患与老龄化相关的疾病,增加诊断测试的医疗保健支出以及精准医疗的扩展预计将为多重检测市场的参与者提供利润丰厚的机会。

市场动态:

多重分析市场是由个人化医疗需求不断增长、蛋白质组学和基因组学领域活跃的研发活动以及多重分析在生物标记研究和临床诊断中的应用不断增长等因素所推动的。然而,检测开发的复杂性和严格的法律规范构成了限制市场成长的挑战。微射流和数位PCR技术的采用将促进高通量、低样本量、可携式多重平台的开发,并创造新的机会。缺乏熟练的专业人员和设备高成本也在一定程度上成为市场拓展的挑战。

多重检测技术的日益普及是市场的主要驱动力。多重检测比传统的单重检测具有许多优势,因为可以在单一实验中同时分析多个标靶。多重检测有可能以多种方式推动市场成长,包括同时测试多种分析物的能力,与手动测试相比,节省时间和精力。透过整合测试,多重检测可以降低与试剂、消耗品和实验室管理费用相关的整体成本。多重检测是高通量筛检的理想选择,可用于大规模研究和临床诊断。多重分析可以对有限的样品量进行分析,并保留有价值的样品,例如切片检查或稀有细胞群。

例如,2021年6月,食品、环境、药品和化妆品检测领域的全球领导者Eurofins宣布开发GSD NovaType III SARS-CoV-2 RT-PCR,用于快速检测SARS-CoV-2变异体。宣布启动我们的检测。该测定在单一反应中鑑定相关突变 E484Q、E484K 和 L452R,同时促进它们与 S 基因 E484 野生型突变体的区分。

研究的主要特点

  • 该报告对全球多重检测市场进行了详细分析,并提供了以2023年为基准年的预测期(2024-2031)的市场规模和年复合成长率(CAGR%)。
  • 它还强调了不同细分市场的潜在收益成长机会,并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
  • 该报告根据公司亮点、产品系列、主要亮点、绩效和策略等参数,介绍了全球多重检测市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、产品升级、市场扩张和行销策略做出明智的决策。
  • 全球多重检测市场报告迎合了该行业的各种相关人员,如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球多重检测市场的各种策略矩阵,将促进相关人员的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规及趋势分析

  • 市场动态
  • 促进因素
  • 抑制因素
  • 机会
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第 4 章 冠状病毒 (COVID-19) 大流行的影响

  • 新型冠状病毒感染疾病(COVID-19)的流行病学
  • 供需面分析
  • 经济影响

第 5 章 全球多重检测市场(按产品),2019-2031 年

  • 消耗品
  • 装置
  • 软体

第六章 全球多重检测市场,依类型,2019-2031

  • 蛋白质多重检测
  • 平面蛋白质测定
  • 以微珠为基础的蛋白质检测
  • 核酸多重检测
  • 平面蛋白质测定
  • 以微珠为基础的蛋白质检测
  • 基于细胞的多重检测

第 7 章 全球多重检测市场(按技术),2019-2031

  • 流式细胞技术
  • 萤光侦测
  • 发光
  • 多重实时 PCR
  • 其他技术

第 8 章全球多重检测市场(按应用),2019-2031 年

  • 研究与开发
  • 药物研发发现与开发
  • 生物标记的发现与检验
  • 临床诊断
  • 感染疾病
  • 癌症
  • 心血管疾病
  • 自体免疫疾病
  • 神经系统疾病
  • 代谢及内分泌疾病
  • 其他疾病

第 9 章 全球多重侦测市场,依最终使用者划分,2019-2031 年

  • 製药和生物技术公司
  • 医院和实验室
  • 研究和学术机构
  • 其他最终用户

第 10 章 全球多重检测市场(按地区),2019-2031

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第十一章竞争形势

  • Luminex Corporation
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • Qiagen
  • Abcam Plc.
  • Becton, Dickinson and Company
  • Merck KGaA
  • Agilent Technologies
  • MESO SCALE DIAGNOSTICS, LLC.
  • Randox Laboratories Ltd.
  • Seegene Inc
  • Perkin Elmer Inc.
  • R&D Systems, Inc.
  • Advanced Cell Diagnostics, Inc.

第12章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6575

The global multiplex assay market size is expected to reach US$ 4.40 Bn by 2031, from US$ 1.69 Bn in 2024, at a CAGR of 14.6% during the forecast period.

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 1.69 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024-2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 14.60% 2030/2031 Value Projection: US$ 4.40 Bn
Figure 1. Global Multiplex Assay Market Share (%), by Region, 2024
Global Multiplex Assay Market - IMG1

The multiplex assay market has been witnessing significant growth in the recent past on account of the rising incidence of chronic and infectious diseases globally. Multiplexing permits simultaneous detection of multiple analytes in a single assay run, which enhances diagnostic accuracy and throughput. It allows laboratories to streamline testing processes while minimizing operational costs. Various technological advancements including microarrays and bead-based techniques have facilitated the development of high-throughput multiplex platforms with high sensitivity and specificity for clinical diagnostics and research applications. Going forward, the growing geriatric population vulnerable to age-related illnesses, increasing healthcare expenditures on diagnostic testing, and expansion of precision medicine are expected to present lucrative opportunities for players in the multiplex assay market.

Market Dynamics:

The multiplex assay market is driven by factors such as growing demand for personalized medicine, robust R&D activity in the field of proteomics and genomics, and increasing applications of multiplex assays in biomarker research and clinical diagnostics. However, complexity of assay development and stringent regulatory framework are some challenges restraining the market growth. Adoption of microfluidics and digital PCR technologies create new opportunities by facilitating development of high-throughput, low sample volume, and portable multiplex platforms. Lack of skilled experts and high cost of instruments also challenge market expansion to some extent.

The growing adoption of multiplex assay techniques is a significant driver for the market. Multiplex assays offer numerous advantages over traditional singleplex assays by allowing the simultaneous analysis of multiple targets in a single experiment, which can drive the market growth in several ways such as multiplex assays can test for multiple analytes at once, saving time and labor compared to running. By consolidating tests, multiplex assays can reduce overall costs associated with reagents and consumables, as well as laboratory overhead. They are ideal for high-throughput screening, making them valuable in large-scale studies and clinical diagnostics. Multiplexing enables analysis from limited sample volumes, preserving precious samples like biopsy material or rare populations of cells.

For instance, in June 2021, Eurofins, the global leader in food, environment, pharmaceutical, and cosmetic product testing, announced the launch of GSD NovaType III SARS-CoV-2 RT-PCR assay, developed for the rapid detection of SARS-CoV-2 variants. The assay facilitates the identification of the relevant mutations E484Q, E484K, and L452R in one reaction combined with the simultaneous discrimination from the S gene E484 wildtype variant.

Key Features of the Study:

  • This report provides an in-depth analysis of the global multiplex assay market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global multiplex assay market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Luminex Corporation, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Qiagen, Abcam Plc., Becton, Dickinson and Company, Merck KGaA, Agilent Technologies, MESO SCALE DIAGNOSTICS, LLC., Randox Laboratories Ltd., Seegene Inc, Perkin Elmer Inc., R&D Systems, Inc., and Advanced Cell Diagnostics, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global multiplex assay market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global multiplex assay market

Detailed Segmentation:

  • By Product
    • Consumables
    • Instruments
    • Software
  • By Type
    • Protein Multiplex Assays
    • Planar Protein Assays
    • Bead-based Protein Assays
    • Nucleic Acid Multiplex Assays
    • Planar Protein Assays
    • Bead-based Protein Assays
    • Cell-based Multiplex Assays
  • By Technology
    • Flow Cytometry
    • Fluorescence Detection
    • Luminescence
    • Multiplex Real-time PCR
    • Other Technologies
  • By Application
    • Research & Development
    • Drug Discovery & Development
    • Biomarker Discovery & Validation
    • Clinical Diagnostics
    • Infectious Diseases
    • Cancer
    • Cardiovascular Diseases
    • Autoimmune Diseases
    • Nervous System Disorders
    • Metabolism & Endocrinology Disorders
    • Other Diseases
  • By End User
    • Pharmaceutical & Biotechnology Companies
    • Hospitals & Diagnostic laboratories
    • Research & Academic Institutes
    • Other End Users
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top Companies in the Multiplex Assay Market:
    • Luminex Corporation
    • Thermo Fisher Scientific, Inc.
    • Illumina, Inc.
    • Bio-Rad Laboratories, Inc.
    • Qiagen
    • Abcam Plc.
    • Becton, Dickinson and Company
    • Merck KGaA
    • Agilent Technologies
    • MESO SCALE DIAGNOSTICS, LLC.
    • Randox Laboratories Ltd.
    • Seegene Inc
    • Perkin Elmer Inc.
    • R&D Systems, Inc.
    • Advanced Cell Diagnostics, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Multiplex Assay Market, By Product
    • Multiplex Assay Market, By Type
    • Multiplex Assay Market, By Technology
    • Multiplex Assay Market, By Application
    • Multiplex Assay Market, By End User
    • Multiplex Assay Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
    • Advancing genomics and proteomics research
    • Increasing focus on precision medicine
    • Increasing product launches
  • Restraints
  • Opportunity
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Multiplex Assay Market, By Product, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Software
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

6. Global Multiplex Assay Market, By Type, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020-2031
    • Segment Trends
  • Protein Multiplex Assays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Planar Protein Assays
  • Bead-based Protein Assays
  • Nucleic Acid Multiplex Assays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Planar Protein Assays
  • Bead-based Protein Assays
  • Cell-based Multiplex Assays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

7. Global Multiplex Assay Market, By Technology, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020-2031
    • Segment Trends
  • Flow Cytometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Fluorescence Detection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Luminescence
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Multiplex Real-time PCR
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Other Technologies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

8. Global Multiplex Assay Market, By Application, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020-2031
    • Segment Trends
  • Research & Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Drug Discovery & Development
  • Biomarker Discovery & Validation
  • Clinical Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Infectious Diseases
  • Cancer
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Nervous System Disorders
  • Metabolism & Endocrinology Disorders
  • Other Diseases

9. Global Multiplex Assay Market, By End User, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020-2031
    • Segment Trends
  • Pharmaceutical & Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Hospitals & Diagnostic laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Research & Academic Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Other End Users
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

10. Global Multiplex Assay Market, By Region, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Country, 2020 - 2031
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/region, 2019-2031,(US$ Bn)
  • South Africa
  • North Africa
  • Central Africa

11. Competitive Landscape

  • Luminex Corporation
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • Qiagen
  • Abcam Plc.
  • Becton, Dickinson and Company
  • Merck KGaA
  • Agilent Technologies
  • MESO SCALE DIAGNOSTICS, LLC.
  • Randox Laboratories Ltd.
  • Seegene Inc
  • Perkin Elmer Inc.
  • R&D Systems, Inc.
  • Advanced Cell Diagnostics, Inc.
  • Analyst Views

12. Section

  • Research Methodology
  • About us